Koers Advaxis, Inc. OTC Bulletin Board
Aandelen
US0076241092
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2022 | 692K 647K | Omzet 2023 | 13K 12,16K | Marktkapitalisatie | 7,94 mln. 7,42 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -38 mln. -35,54 mln. | Nettowinst (verlies) 2023 | -48 mln. -44,89 mln. | EV/omzet 2022 * | - |
Nettoliquiditeiten 2022 | 657K 614K | Nettoschuld 2023 | 3,43 mln. 3,21 mln. | EV/omzet 2023 | 875 x |
K/w-verhouding 2022 * |
-
| K/w-verhouding 2023 |
-0,08
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 0% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ken Berlin
CEO | Chief Executive Officer | 59 | 23-04-18 |
- | - | ||
- | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Sidransky
CHM | Chairman | 64 | 16-07-13 |
Roni Appel
CEO | Chief Executive Officer | 57 | 01-11-04 |
Murray Goldberg
BRD | Director/Board Member | 79 | 19-01-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+8,57% | 41,34 mld. | |
+49,22% | 41,61 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers ADXS
- Koers